Table 2. Clinical Characteristics of the INFORM ACS Cohort.
| Patient Characteristics | n = 705 |
| Age | 60.6±12.5 |
| Sex | |
| Male | 449 (63.7%) |
| Female | 256 (36.3%) |
| Race | |
| Caucasian | 552 (78.3%) |
| African American | 126 (17.9%) |
| Other | 27 (3.8%) |
| Prior MI | 236 (33.5%) |
| Prior PCI | 221 (31.3%) |
| Prior CABG | 128 (18.2%) |
| Chronic HF | 55 (7.8%) |
| HTN | 464 (65.8%) |
| Hyperlipidemia | 427 (60.6%) |
| DM Known on Arrival | 200 (28.4%) |
| Admit BMI | 29.6±6.3 |
| Admit systolic BP | 137.1±26.9 |
| EF | 47.2±12.9 |
| Admit Glucose | 148.2±83.0 |
| ACS Type | |
| STEMI | 201 (28.5%) |
| NSTEMI | 215 (30.5%) |
| USA | 289 (41.0%) |
| Cardiac catheterization | 576 (81.7%) |
| Treatment | |
| Medical management | 264 (37.4%) |
| PCI | 409 (58.0%) |
| CABG | 32 (4.5%) |
| Discharge Medications - BB | 566 (80.5%) |
Abbreviations: MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, HF heart failure, HTN hypertension, DM diabetes mellitus, BMI body-mass index, BP blood pressure, EF ejection fraction, ACS acute coronary syndrome, STEMI ST-elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction, USA unstable angina, BB beta-blockers.